603880 Jiangsu Nanfang Medical
- 5.04
- +0.11+2.23%
Jiangsu Nanfang Medical News
Nanyue Co., Ltd. (603880.SH): Xu Dong has cumulatively reduced his shareholding by 0.94%.
On December 12, Glonghui reported that Nanwei Co., Ltd. (603880.SH) announced that on August 22, 2024, the company will disclose the "Shareholding Reduction Plan Announcement for Shareholders Holding More Than 5% of Nanwei Co., Ltd.": Within 90 days after 15 trading days from the date of this announcement, Mr. Xu Dong plans to reduce his shareholding through centralized bidding, with the number of shares not exceeding 2,890,420, which is no more than 1% of the total shares of the company. Within 90 days after 15 trading days from the date of this announcement, Mr. Xu Dong plans to reduce his shareholding through block trading, with the number of shares not exceeding 5,780,840, which is no more than 2% of the total shares of the company.
Nanwei Co., Ltd.: Nanwei Co., Ltd. report for the third quarter of 2024
Nanwei Co., Ltd. 2024 Third Quarter Report
Express News | Jiangsu Nanfang Medical Says Controlling Shareholder, Chief Financial Officer Probed by Chinese Securities Regulator for Suspected Insider Trading
October 24th A-share Investment Lightning Rod: infotmic co.,ltd: related parties involved in the restructuring suspected of leaking insider information have been filed; Nanwei Health: controlling shareholders and executives suspected of insider trading ha
Chairman Gu Qingwei of Beijing Dinghan Technology Group plans to reduce his shareholding by no more than 2%; Shareholder Yang Minghuan of Hebei Changshan Biochemical Pharmaceutical plans to reduce his shareholding by no more than 1%; Shareholder Anhui Jintong of Shandong Fengyuan Chemical plans to reduce his shareholding by no more than 3.00%; Shareholder CS Holdings of CSD Water Service, Xu Guodong, plans to collectively reduce their shareholdings by no more than 3.00%; Nanwei Shareholding shareholder and senior executives are under investigation by the China Securities Regulatory Commission for suspected insider trading; Infotmic Co.,Ltd. stated that related parties in the restructuring are suspected of leaking insider information and are under investigation; Tus Environmental Science and Technology Development Company has been included in the list of dishonest persons subject to enforcement.
Selected Announcement | Goertek Inc.: Net income in the first three quarters was 2.345 billion yuan, a year-on-year increase of 162.88%; Nanwei Inc.: The controlling shareholder and senior executives are under investigation by the CSRC for alleged insider
Zhejiang Jingu: Hangzhou Avatar plans to introduce global strategy investors, with this round of financing amounting to 0.8 billion yuan-1.2 billion yuan.
Gelonghui Announcement Highlights | Goertek Inc.: Net income for the first three quarters was 2.345 billion yuan, a year-on-year increase of 162.88%; Nanwei Inc.: Controlling shareholder and senior executives under investigation for alleged insider tradin
【Performance Report】goertek inc. (002241.SZ): The net income in the first three quarters was 2.345 billion yuan, a year-on-year increase of 162.88%. zhonghang electronic measuring instruments (300114.SZ): The net income in the first three quarters was 0.103 billion yuan, a year-on-year increase of 4.08%. Shouchuang Securities (601136.SH): The net income in the first three quarters was 0.75 billion yuan, a year-on-year increase of 63.1%. nanjing gaoke (600064.SH): The net income in the first three quarters was 1.838 billion yuan, a year-on-year increase of 10.08%. shanghai datun energy resources (600508.SH): The net income in the first three quarters was 0.626 billion yuan, a year-on-year decrease of 52.
Nanwei Corporation (603880.SH): Shareholder Xu Dong's shareholding proportion has decreased to 4.997%.
Grain Long Hui October 17th | Nanwei Stock (603880.SH) announced that shareholder Mr. Xu Dong, from September 24, 2024 to October 16, 2024, through the Shanghai Stock Exchange centralized bidding method, accumulated a reduction of 1,220,821 shares of the company's stocks, accounting for 0.422% of the total share capital of the company. Mr. Xu Dong's shareholding in the company decreased from 5.419% to 4.997%.
Nanwei Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Nanwei Co., Ltd.
Nanwei Co., Ltd. (603880.SH): The net income in the first half of the year was approximately 1.03 million yuan, a decrease of 87.01% year-on-year.
On August 29th, Guangrong Investment announced that its revenue for the first half of 2024 was approximately 0.302 billion yuan, a decrease of 14.45% compared to the same period last year. The net income attributable to shareholders of the listed company was approximately 1.03 million yuan, a decrease of 87.01% compared to the same period last year. The basic earnings per share was 0.004 yuan.
August 22nd A-shares lightning rod | Nanwei shares: Xu Dong plans to reduce shareholding by no more than 3%; china grand automotiveservices group: the company's stocks and convertible bonds will be delisted on August 28.
Nanwei Holdings shareholder Xu Dong plans to reduce shareholding by no more than 3%; China Grand Automotiveservices Group said the company's stocks and convertible bonds will be delisted on August 28; Fujian Furi Electronics reported a net loss of 93.5957 million yuan in the first half of the year; Zhejiang Publishing Media said it is only the publisher of the game 'Black Myth: Wukong' and does not participate in revenue sharing; Qitian Technology said there is no business cooperation with the game 'Black Myth: Wukong'.
Nanwei Corporation (603880.SH): The individual first aid kit has not yet carried out export trade business.
On August 6, Gelunhui reported that Nanwei Corporation (603880.SH) stated on the interactive platform that the company has not yet launched export trade business for its individual first-aid kits.
Jiangsu Nanfang Medical (603880.SH): Revocation of other risk warnings and suspension
On June 24th, Gelunhui reported that according to the relevant regulations of the Shanghai Stock Exchange Listing Rules, the company's stocks will be suspended from trading for 1 day starting from June 25, 2024, and will resume trading and cancel other risk warnings on June 26, 2024. After canceling other risk warnings, the company's stocks will be traded on the risk warning board. The stock abbreviation will be changed from "ST Nanwei" to "Nanwei Shares", and the daily trading limit for the company's stock will be changed from 5% to 10%. The stock code remains 603880.
Jiangsu Nanfang Medical (603880.SH) stock applies to cancel other risk warnings.
Jiangsu Nanfang Medical (603880.SH) announced that, according to the relevant provisions of the Shanghai Stock Exchange Listing Rules (revised in 2024), other risk warnings involving the company have been eliminated, and there is no situation of triggering other risk warnings. Therefore, the company has applied to the Shanghai Stock Exchange to cancel the other risk warnings imposed on the company's stock.
ST Nanwei (603880.SH) announced first-quarter results, net profit of 1.75 million yuan, a year-on-year decrease of 74.82%
ST Nanwei (603880.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 1.3 during the reporting period...
ST Nanwei (603880.SH) announced 2023 annual results with a net loss of 147 million yuan
According to the Zhitong Finance App, ST Nanwei (603880.SH) disclosed the 2023 annual report. The company achieved revenue of 600 million yuan in 2023, an increase of 10.03%; net profit loss to mother was 147 million yuan, an increase over the previous year; loss after deducting non-net profit of 147 million yuan, a year-on-year increase; and basic earnings per share were -0.51 yuan. During the reporting period, the company's main business revenue increased slightly compared to last year; the decrease in net profit attributable to the parent company was mainly due to an oversupply of protective equipment, and price competition was intense; credit impairment losses and asset impairment losses increased.
ST Nanwei (603880.SH): There is no business involved in the AI medical field yet
Gelonghui, March 19丨ST Nanwei (603880.SH) said on the investor interactive platform that the company has no business involved in the AI medical field yet.
ST Nanwei (603880.SH): Shareholder Xu Dong has purchased 1.5565 million shares of the company
Gelonghui, Feb. 20 | ST Nanwei (603880.SH) announced that today the company received a notice from Mr. Xu Dong, a shareholder of more than 5%: As of February 20, 2024, Mr. Xu Dong had purchased 1,056,500 shares of the company through self-funded centralized bidding transactions in the secondary market. All proceeds from this share repurchase are owned by the listed company.
Jiangsu Nanfang Medical Co., Ltd. (SHSE:603880) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
No Data
